378O Persistence under abemaciclib and endocrine treatment (ABA+ET) in patients with advanced breast cancer (aBC): First results of the randomized IMPACT trial comparing patient coaching with the MASCC oral agent teaching tool (MOATT) versus local routine patient coaching (LC)
Manfred Welslau(Klinikum Aschaffenburg), PA Fasching(Universitätsklinikum Erlangen), Lothar Mueller, Erik Belleville, Lorenz Rieger, M-O. Zahn, B. Lex, Lothar Häberle(Universitätsklinikum Erlangen), Hans Tesch(Klinikum Aschaffenburg)
Cited by 5Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis